Gamco, Gabelli investors add to shares of Biosite

By Lisa Kerner

Charlotte, N.C., June 19 - Biosite Inc. shareholders led by Gamco Asset Management Inc. and Gabelli Funds, LLC continued to increase their stake in the company with the purchase of 250,851 shares of the company's stock between June 11 and June 15, priced from $92.14 to $92.22.

The investors beneficially own 2,279,730 shares, or 13.34%, of the San Diego-based biomedical company's outstanding stock, according to a schedule 13D filed with the Securities and Exchange Commission.

On June 12, the investors reported an 11.87% stake in Biosite, an increase from the 9.8% reported on May 23.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.